Physician profile
David Maynoldi
NPI 1144591249
$4,345.48
in general payments reported to CMS, 2019-2025
26 companies · $121 in 2025
The $121 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.95 · 2021: $23.36 · 2022: $217 · 2023: $217 · 2024: $3,681 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $3,500 · Food and Beverage: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $3,500.00 |
| Food and Beverage | $518.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Photonicare INC | $3,531.25 | 2023-2024 | Otosight Middle Ear Scope |
| Pfizer INC. | $95.09 | 2019-2022 | |
| Antares Pharma, INC. | $73.52 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Corcept Therapeutics | $72.49 | 2023-2024 | Korlym |
| Mannkind Corporation | $59.40 | 2022 | |
| Medtronic, INC. | $52.36 | 2022-2023 | Intellis Adaptivestim, Venaseal |
| Lilly USA, LLC | $50.20 | 2024-2025 | Jardiance |
| Amgen INC. | $49.65 | 2022-2023 | Enbrel, Otezla |
| Exact Sciences Corporation | $49.21 | 2024-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $27.77 | 2024 | |
| Saluda Medical Americas, INC. | $27.28 | 2025 | Evoke |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.11 | 2019 | |
| Globus Medical, INC. | $23.70 | 2025 | Senza |
| Janssen Pharmaceuticals, INC | $17.78 | 2024 | Spravato |
| Abbvie INC. | $17.58 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $17.56 | 2024 | Inspire |
| Medtronic Vascular, INC. | $17.31 | 2019 | |
| Novo Nordisk INC | $17.13 | 2024 | Rybelsus, Ozempic |
| Shield Therapeutics INC | $16.93 | 2022 | |
| Glaxosmithkline, LLC. | $16.35 | 2022 | |
| Axsome Therapeutics, INC. | $16.15 | 2023 | Sunosi |
| Inari Medical, INC. | $15.25 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Otsuka America Pharmaceutical, INC. | $15.04 | 2025 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $14.57 | 2023 | |
| Emd Serono, INC. | $14.16 | 2023 | Mavenclad |
| Horizon Therapeutics Plc | $13.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Maynoldi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.